List of insiders holdings for NEKTAR THERAPEUTICS:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Deep Track Capital LP Deep Track Biotechnology Master Fund Ltd. KROIN DAVID 10% Owner | 2024-11-14 09:18:10 | 15,922,655 0 | 15,922,655 | Form 13G |
ROBIN HOWARD W President & CEO | 2024-12-19 21:08:56 | 1,110,675 410 | 1,111,085 | Form 4 |
Wilson Mark Andrew Chief Legal Officer | 2024-12-17 20:54:48 | 1,042,169 0 | 1,042,169 | Form 4 |
HARRIS J MILTON President of Nektar AL | 2004-03-19 21:07:22 | 0 743,904 | 743,904 | Form 4/A |
Zalevsky Jonathan Chief R&D Officer | 2024-12-20 20:33:46 | 326,904 0 | 326,904 | Form 4 |
PATTON JOHN STUART Chief Scientific Officer | 2008-11-18 15:11:07 | 313,880 0 | 313,880 | Form 4 |
Thomsen Jillian B. Chief Financial Officer | 2023-02-17 20:58:41 | 313,497 0 | 313,497 | Form 4 |
Labrucherie Gil M SVP, COO & CFO | 2022-05-17 21:32:02 | 312,905 0 | 312,905 | Form 4 |
CHESS ROBERT Director | 2024-06-14 18:02:51 | 255,273 6,300 | 261,573 | Form 4 |
NORTHCOTT JOHN SVP & Chief Commercial Officer | 2022-05-17 21:33:45 | 223,210 0 | 223,210 | Form 4 |
HARKNESS TIMOTHY SVP & Chief Financial Officer | 2007-09-21 17:48:19 | 200,000 0 | 200,000 | Form 4/A |
Nicholson John SVP & Chief Operating Officer | 2019-08-19 19:07:55 | 162,759 0 | 162,759 | Form 4 |
GLAVIN JAMES B Director | 2003-09-05 18:01:27 | 149,600 0 | 149,600 | Form 4 |
PERELMAN MELVIN Director | 2004-09-03 13:08:23 | 147,500 0 | 147,500 | Form 4 |
Ajer Jeffrey Robert Director | 2023-09-20 20:06:32 | 119,153 0 | 119,153 | Form 4 |
Curet Myriam Director | 2023-09-20 20:09:30 | 112,418 0 | 112,418 | Form 4 |
Doberstein Stephen K SVP & Chief Scientific Officer | 2019-09-09 17:09:44 | 107,668 0 | 107,668 | Form 4 |
Gergel Ivan P. SVP & Chief Medical Officer | 2017-11-17 18:03:51 | 106,553 0 | 106,553 | Form 4 |
Krivulka Joseph J Director | 2017-09-21 16:46:21 | 104,500 0 | 104,500 | Form 4 |
CHOWRIRA BHARAT M Chief Operating Officer | 2010-02-03 12:00:07 | 100,000 0 | 100,000 | Form 4 |
Ghosh Rinko Chief Business Officer | 2013-02-08 16:13:45 | 100,000 0 | 100,000 | Form 4 |
Hora Maninder SVP Pharma Dev & Mfg Ops | 2019-05-17 20:19:53 | 94,694 0 | 94,694 | Form 4 |
GILL AJIT President & CEO | 2006-03-24 18:15:08 | 0 87,991 | 87,991 | Form 4 |
Elam Nevan C SVP & Head of Pulmonary Bus | 2008-02-27 19:38:59 | 85,000 0 | 85,000 | Form 4 |
Moreadith Randall W SVP Drug Development | 2009-02-25 12:15:21 | 85,000 0 | 85,000 | Form 4 |
Brainard Diana Director | 2023-09-20 20:07:26 | 85,000 0 | 85,000 | Form 4 |
GREER R SCOTT Director | 2023-09-21 20:07:09 | 85,000 0 | 85,000 | Form 4 |
WHITFIELD ROY A Director | 2023-09-20 20:11:17 | 85,000 0 | 85,000 | Form 4 |
Lorianne Masuoka K. Chief Medical Officer | 2011-02-10 16:56:49 | 75,000 0 | 75,000 | Form 4 |
WINGER DENNIS L Director | 2018-08-21 19:32:27 | 57,750 5,000 | 62,750 | Form 4 |
KUEBLER CHRISTOPHER A Director | 2018-10-01 20:23:50 | 54,750 0 | 54,750 | Form 4 |
WANG SUSAN Director | 2015-11-20 17:27:10 | 54,128 0 | 54,128 | Form 4 |
Lingnau Lutz Director | 2020-09-25 20:14:42 | 54,000 0 | 54,000 | Form 4/A |
EASTHAM KARIN Director | 2022-09-20 20:47:33 | 43,633 0 | 43,633 | Form 4 |
Medve Robert SVP & Chief Medical Officer | 2014-02-07 13:46:41 | 25,000 0 | 25,000 | Form 4 |
LERNER IRWIN Director | 2008-12-04 16:26:05 | 20,000 0 | 20,000 | Form 4 |
Huh Hoyoung Director | 2008-12-04 16:29:12 | 20,000 0 | 20,000 | Form 4 |
BROWN MICHAEL A Director | 2009-09-17 18:08:16 | 20,000 0 | 20,000 | Form 4 |
Johnston David SVP, Research & Development | 2007-05-15 10:30:16 | 14,600 0 | 14,600 | Form 4 |
DRAPEAU LOUIS Sr. VP Finance, CFO | 2007-05-14 15:19:51 | 6,000 0 | 6,000 | Form 4 |
BANSAL AJAY Former CFO | 2006-03-13 14:35:32 | 5,166 0 | 5,166 | Form 4 |
GARDINER SANDRA A. Chief Financial Officer | 2023-04-25 21:03:08 | 0 0 | 0 | Form 3 |